NFKB1 and lung carcinoma: Furthermore, gigantol has been reported to inhibit lung cancer cell proliferation by inducing ubiquitin–proteasomal degradation [30] and attenuate diabetic nephropathy via the suppression of the ROS/MAPK/NF-κB signaling pathway [31].